An anti-parasitic drug could be the COVID-19 antiviral we need
Researchers from Australia have confirmed that an FDA-approved anti-parasitic agent called Ivermectin can inhibit SARS-Cov2 replication in…
The Encyclopedia of Science's Frontier
Researchers from Australia have confirmed that an FDA-approved anti-parasitic agent called Ivermectin can inhibit SARS-Cov2 replication in…